CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment, before Tax (Deprecated 2012-01-31)
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) reported Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment, before Tax (Deprecated 2012-01-31) of $921.00 thousand for the 12-month period ending 2012-12-29, per its 10-K filed 2013-02-27.
Discontinued › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeAvailableForSaleSecuritiesAdjustmentBeforeTaxPeriodIncreaseDecrease · last filed 2013-02-27
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. other comprehensive income (loss), available-for-sale securities adjustment, before tax (deprecated 2012-01-31) for fiscal 2012 was $921.00K.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. other comprehensive income (loss), available-for-sale securities adjustment, before tax (deprecated 2012-01-31) for fiscal 2011 was -$325.00K, a 138.06% decline from fiscal 2010.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. other comprehensive income (loss), available-for-sale securities adjustment, before tax (deprecated 2012-01-31) for fiscal 2010 was $854.00K.
| Period end | Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment, before Tax (Deprecated 2012-01-31) 12 month |
|---|---|
| 2012-12-29 | $921.00K 10-K · filed 2013-02-27 |
| 2011-12-31 | -$325.00K 10-K · filed 2013-02-27 |
| 2010-12-25 | $854.00K 10-K · filed 2012-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |